Pancreatic Cancer Research

ResearcherUniversity of VeronaNo recent work listed

Paola Capelli

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5105695913. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 2 papers

Papers 12

  1. Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000004552↗
  2. Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol. Co-author DOI 10.1245/s10434-022-11417-3↗
  3. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2020.04.006↗
  4. A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial. Co-author DOI 10.1177/1758835920947969↗
  5. Pancreatico-gastric fistula mimicking malignant infiltration following transgastric EUS-FNA of resectable pancreatic ductal adenocarcinoma. Last author DOI 10.4103/eus.eus_5_20↗
  6. Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study. Co-author DOI 10.3390/cancers11020267↗
  7. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? Co-author DOI 10.1245/s10434-017-5885-4↗
  8. Pancreatic Ductal Adenocarcinoma and Its Variants. First author DOI 10.1016/j.path.2016.05.003↗
  9. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  10. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Co-author DOI 10.1016/j.amjsurg.2011.03.008↗
  11. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? Co-author DOI 10.1016/j.surg.2012.05.017↗
  12. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Co-author DOI 10.1245/s10434-011-1769-1↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Giuseppe Malleo · 6 shared papers, 2017–2022 · strength 0.64
  2. Claudio Bassi · 7 shared papers, 2012–2022 · strength 0.62
  3. Roberto Salvia · 5 shared papers, 2019–2022 · strength 0.53
  4. Claudio Luchini · 4 shared papers, 2016–2022 · strength 0.47
  5. Aldo Scarpa · 4 shared papers, 2016–2022 · strength 0.45
  6. Salvatore Paiella · 4 shared papers, 2020–2022 · strength 0.45
  7. Laura Maggino · 4 shared papers, 2017–2022 · strength 0.43
  8. Giovanni Marchegiani · 4 shared papers, 2019–2022 · strength 0.39
  9. Mirko D’Onofrio · 5 shared papers, 2011–2020 · strength 0.27
  10. Fabio Casciani · 2 shared papers, 2020–2022 · strength 0.24
  11. Alessandro Esposito · 2 shared papers, 2020–2022 · strength 0.21
  12. Gabriella Lionetto · 1 shared paper, 2022 · strength 0.14
  13. Marco Le Grazie · 1 shared paper, 2020 · strength 0.13
  14. Stefano Francesco Crinò · 1 shared paper, 2020 · strength 0.13
  15. Carlos F. Fernandez-del Castillo · 1 shared paper, 2022 · strength 0.13
  16. Mari A. Mino-Kenudson · 1 shared paper, 2022 · strength 0.13
  17. Motaz Qadan · 1 shared paper, 2022 · strength 0.13
  18. Cristina Rosa Ferrone · 1 shared paper, 2022 · strength 0.13
  19. Keith D. Lillemoe · 1 shared paper, 2022 · strength 0.13
  20. Filippo Scopelliti · 2 shared papers, 2017–2020 · strength 0.13
  21. Paolo Regi · 2 shared papers, 2017–2020 · strength 0.13
  22. Alessandro Giardino · 2 shared papers, 2017–2020 · strength 0.13
  23. Isabella M. Frigerio · 2 shared papers, 2017–2020 · strength 0.13
  24. Giovanni Butturini · 2 shared papers, 2017–2020 · strength 0.13
  25. Paolo Pederzoli · 3 shared papers, 2011–2012 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.